Track 5: Ventilator-associated pneumonia

Hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) are important causes of morbidity and mortality, with mortality rates approaching 62%. HAP and VAP are the second most common cause of nosocomial infection overall, but are the most common cause documented in the intensive care unit setting. In addition, HAP and VAP produce the highest mortality associated with nosocomial infection.

    Related Conference of Track 5: Ventilator-associated pneumonia

    February 20-21, 2019 |

    8th Annual Summit on Microbiology

    San Francisco, California, USA
    March 18-19, 2019

    3rd International Conference on Microbial Ecology & Eco Systems

    Chicago, Illinois, USA
    (10 Plenary Forums 2 days 1 event)
    March 04-06, 2019

    9th Global Summit on Microbiology & Infectious Diseases

    Prague, Czech Republic
    May 01-02, 2019

    3rd International Conference on Medical and Clinical Microbiology

    | ANA Crowne Plaza | Kyoto, Japan
    May 20-21, 2019

    4th International Conference on Applied Microbiology and Beneficial Microbes

    | Radisson Hotel Narita | Tokyo , Japan
    June 24-25, 2019

    48th World Congress on Microbiology

    Moscow, Russia
    July 01-02, 2019

    11th International Virology Summit

    Valencia, spain
    July 26-27, 2019

    World Yeast Congress

    Vancouver | Canada
    October 23-24, 2019

    2nd Global Experts Meeting on Chronic Diseases

    | Radisson Hotel Narita | Tokyo, Japan
    24-25 October, 2019

    6th World Congress and Expo on Applied Microbiology

    Rome, Italy
    December 12-13, 2019

    23rd World Congress on Biotechnology

    Auckland, New Zealand

    Track 5: Ventilator-associated pneumonia Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in